Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Aytu Biopharma Inc
(NQ:
AYTU
)
2.390
-0.020 (-0.83%)
Streaming Delayed Price
Updated: 3:59 PM EDT, Aug 9, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Aytu Biopharma Inc
< Previous
1
2
3
4
5
6
7
8
Next >
Earnings Scheduled For February 14, 2023
February 14, 2023
Companies Reporting Before The Bell • WESCO International (NYSE:WCC) is projected to report quarterly earnings at $3.79 per share on revenue of $5.37 billion.
Via
Benzinga
Earnings Preview For Aytu BioPharma
February 13, 2023
Via
Benzinga
Aytu BioPharma to Report Second Quarter Fiscal 2023 Financial Results on February 14, 2023
February 07, 2023
Via
ACCESSWIRE
Aytu BioPharma Regains Nasdaq Minimum Bid Price Compliance
January 25, 2023
Via
ACCESSWIRE
Aytu BioPharma to Present at Lytham Partners Investor Select Conference on January 31
January 24, 2023
Via
ACCESSWIRE
Aytu BioPharma, Inc Continues Availability of Adzenys XR-ODT(R) as the Only FDA-Approved Orally Disintegrating Tablet (ODT) Medication that is Bioequivalent to Adderall XR(R) for ADHD Patients
January 10, 2023
Via
ACCESSWIRE
12 Health Care Stocks Moving In Thursday's After-Market Session
January 05, 2023
Via
Benzinga
Aytu BioPharma Ranked Among Fastest-Growing Companies in North America on Deloitte's Technology Fast 500(TM) for Second Year in a Row
November 17, 2022
Via
ACCESSWIRE
Aytu BioPharma Reports Record Quarterly Revenue and Positive Adjusted EBITDA in First Quarter of Fiscal Year 2023
November 14, 2022
Via
ACCESSWIRE
Aytu BioPharma Announces Agreement with Avenue Venture Debt Fund to Extend Interest-Only Period of Company's Term Loan
October 25, 2022
Via
ACCESSWIRE
Aytu BioPharma Announces 1-for-20 Reverse Stock Split
January 05, 2023
Via
ACCESSWIRE
12 Health Care Stocks Moving In Monday's After-Market Session
December 26, 2022
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
December 26, 2022
Via
Benzinga
Muscle Maker And 2 Other Stocks Under $1 Insiders Are Aggressively Buying
December 22, 2022
The Dow Jones settled higher by more than 500 points on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or...
Via
Benzinga
Aytu BioPharma Announces Highest Weekly Adzenys XR-ODT(R) Prescriptions Generated Since Inception of RxConnect
November 30, 2022
Via
ACCESSWIRE
Aytu BioPharma Announces Strategic Shift, Indefinite Suspension of Clinical Development Programs
October 13, 2022
Via
Benzinga
Aytu BioPharma Announces Continuing Availability of ADHD Medication Adzenys XR-ODT(R) in Response to Reported Generic Adderall(R) XR Supply Disruptions
October 05, 2022
Via
ACCESSWIRE
Aytu BioPharma Reports Record Fourth Quarter and Fiscal Year 2022 Revenue
September 27, 2022
Via
ACCESSWIRE
12 Health Care Stocks Moving In Thursday's Intraday Session
November 24, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
November 23, 2022
Via
Benzinga
Aytu BioPharma Receives a 180-Day Extension by Nasdaq to Regain Compliance with Bid Price Rule
November 22, 2022
Via
ACCESSWIRE
Aytu BioPharma Announces the Passing of Co-Founder and Board Member Michael Macaluso
November 16, 2022
Via
ACCESSWIRE
Why Array Technologies Shares Are Trading Sharply Higher; Here Are 28 Stocks Moving Premarket
November 09, 2022
Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) shares jumped 32% to $1.65 in pre-market trading. NeuroBo reported closing of $32.3 million underwritten public offering including full exercise of...
Via
Benzinga
Aytu BioPharma to Report First Quarter Fiscal 2023 Financial Results on November 14, 2022
November 07, 2022
Via
ACCESSWIRE
12 Health Care Stocks Moving In Thursday's Pre-Market Session
October 13, 2022
Gainers Corbus Pharmaceuticals (NASDAQ:CRBP) shares rose 24.6% to $0.14 during Thursday's pre-market session. The market value of their outstanding shares is at $17.1 million.
Via
Benzinga
Aytu BioPharma Announces Strategic Shift to Focus on Commercial Operations and Indefinite Suspension of Clinical Development Programs
October 13, 2022
Via
ACCESSWIRE
11 Health Care Stocks Moving In Wednesday's Pre-Market Session
October 05, 2022
Gainers Bionano Genomics (NASDAQ:BNGO) stock increased by 9.8% to $2.24. The company's market cap stands at $649.9 million.
Via
Benzinga
Aytu BioPharma's Return On Capital Employed Insights
September 28, 2022
According to data from Benzinga Pro, during Q4, Aytu BioPharma's (NASDAQ:AYTU) reported sales totaled $27.45 million. Despite a 66.65% increase in earnings, the company posted a loss of $17.70...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
September 27, 2022
Gainers Benitec Biopharma (NASDAQ:BNTC) shares increased by 9.8% to $0.35 during Tuesday's after-market session. The company's market cap stands at $9.0 million.
Via
Benzinga
Earnings Scheduled For September 27, 2022
September 27, 2022
Companies Reporting Before The Bell • Ferguson (NYSE:FERG) is projected to report quarterly earnings at $2.79 per share on revenue of $7.86 billion.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit